Shufro Rose & Co’s Biogen BIIB Stock Holding History

Shufro Rose & Co’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,521	Closed	-$407K	–	286
2020 Q2	$407K	Buy	1,521 +21	+1%	+$6.31K	0.04%	173
2020 Q1	$475K	Hold	1,500	–	–	0.06%	143
2019 Q4	$445K	Hold	1,500	–	–	0.04%	178
2019 Q3	$349K	Hold	1,500	–	–	0.03%	201
2019 Q2	$351K	Hold	1,500	–	–	0.03%	200
2019 Q1	$355K	Hold	1,500	–	–	0.04%	197
2018 Q4	$451K	Hold	1,500	–	–	0.05%	167
2018 Q3	$530K	Hold	1,500	–	–	0.05%	168
2018 Q2	$435K	Hold	1,500	–	–	0.04%	174
2018 Q1	$411K	Hold	1,500	–	–	0.04%	184
2017 Q4	$478K	Hold	1,500	–	–	0.05%	168
2017 Q3	$470K	Buy	+1,500	New	+$444K	0.05%	168
2014 Q2	–	Sell	-1,000	Closed	-$305K	–	262
2014 Q1	$305K	Hold	1,000	–	–	0.03%	198
2013 Q4	$279K	Buy	+1,000	New	+$259K	0.03%	207
2013 Q3	–	Sell	-1,000	Closed	-$215K	–	256
2013 Q2	$215K	Buy	+1,000	New	+$214K	0.03%	215

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Shufro Rose & Co's BIIB Position: Q3 2020 in Review

Shufro Rose & Co sold out of Biogen (BIIB) in Q3 2020, closing a stake of 1,521 shares — an estimated $407K sold.

Shufro Rose & Co first reported a position in BIIB in Q2 2013 and held it in 15 quarters. The position peaked at $530K in Q3 2018. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

Shufro Rose & Co reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
Shufro Rose & Co sold 1,521 Biogen shares in Q3 2020, an estimated $407K.
Shufro Rose & Co first reported a position in Biogen in Q2 2013 and held it in 15 quarters.
Shufro Rose & Co's Biogen position peaked at $530K in Q3 2018.
1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Shufro Rose & Co's 13F filing for Q3 2020, filed 27 Oct 2020.